By Dave Sebastian

 

Johnson & Johnson said up to 200,000 Ebola vaccine regimens will be made available as part of a World Health Organization early access clinical program underway in Sierra Leone.

The WHO and the Sierra Leone government have started administering the vaccine regimen as part of an effort to prevent the further spread of Ebola in West Africa, the company said Thursday.

J&J said its vaccine regimen, developed with Bavarian Nordic A/S, also received prequalification from the WHO. The regimen is being donated to the WHO, the company said.

 

Write to Dave Sebastian at dave.sebastian@wsj.com

 

(END) Dow Jones Newswires

May 13, 2021 08:42 ET (12:42 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.